CHA HEALTH SYSTEMS

CHA Health Systems (CHS), Inc. is a U.S holding company of CHA Health Systems, Korea. CHS owns and operates Hollywood Presbyterian Medical Center (HPMC) which is the one of the largest privately-owned hospitals in Los Angeles with 434 beds. Also, CHS operates Urgent Care Center and LA CHA Fertility Center, known as a leading fertility center and the first commercial ovum bank in the U.S to provide full range of services as Infertility testing, Ovulation induction, Donor egg and surrogacy, Husband and Donor IUI, IVF, ICSI, AH, Blastocyst Transfer, etc.
CHA Health Systems, Korea, established in 1960, has received worldwide recognition and accolades for its excellence in research and clinical translation. It continued its international expansion and formed CHAUM, a premier anti-aging center and research centers in the U.S. and Korea. The Company’s activities also include various medical and biotech ventures, including a healthcare investment firm, CHA Bio & Diostech, the leading bio-tech company in the field of stem cell research and treatment development and CMG Pharmaceuticals, both listed on KOSDAQ.
With the ultimate vision of becoming a global leader in the next generation of healthcare services, CHS continues to stay at the forefront of medical services by building its global network of hospitals/clinics and research institutes for the advancement of bio-medicine and bio-ventures.